Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

venetoclax 152Cytarabine 114Cyclophosphamide 110Specimen Handling 101Azacitidine 99fludarabine 89Biopsy 76Rituximab 48Methotrexate 45Daunorubicin 44fludarabine phosphate 42Vincristine 38Dexamethasone 37Magnetic Resonance Spectroscopy 36Injections 34Decitabine 34blinatumomab 31Granulocyte Colony-Stimulating Factor 30Mycophenolic Acid 29Whole-Body Irradiation 28Prednisone 28Idarubicin 28ibrutinib 27Tacrolimus 27Etoposide 27Doxorubicin 27Busulfan 27Melphalan 24acalabrutinib 23Mercaptopurine 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Methylprednisolone Acetate × Other hematologic neoplasm × 90 days × Clear all
NCT04438382 2026-06-02

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Eastern Cooperative Oncology Group

Phase 2 Terminated
1 enrolled 1 chart
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡